Found 443 matching trials
Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors
NAThis study is a Compassionate clinical study for the treatment of Malignant...
Location
Hadassah Ein Kerem
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
N/AThis screening study is intended for men and women ≥ 18 to ≤ 75 years of ag...
An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation
PHASE3The purpose of this study is to evaluate the effectiveness and safety of ep...
Location
Multiple Locations
A Study of SHR-A1921 for Injection in Subjects With Advanced Solid Tumours
PHASE1To assess the safety and tolerability of SHR-A1921 in patients with advance...
Location
Multiple Locations
The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors
NAMultimodal thermal therapy (MTT), as an initiative integration of cryothera...
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
PHASE1The goal of this Phase I clinical trial is to evaluate how the imaging drug...
Location
Excel Diagnostics & Nuclear Oncology Center
SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites
PHASE1This study is divided into two phases. Patients with recurrent or metastati...
Location
Multiple Locations
TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia
NAThis is a clinical study of TAA6 cell injection in the treatment of patient...
Location
Anhui Provincial Hospital
Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
PHASE2This study aims to evaluate the efficacy and safety of QLS31905 and/or QL17...
Location
Beijing Cancer Hospital
LAM561 With RT and TMZ for Adults With Glioblastoma
PHASE2The proposed Phase IIB/III randomized, double-blind, placebo-controlled tri...
Status
Active Not Recruiting
Location
Institut Cancerologie de L'Ouest (ICO)